Logo image of ETHZ

ETHZILLA CORP (ETHZ) Stock Fundamental Analysis

USA - NASDAQ:ETHZ - US68236V3024 - Common Stock

10.37 USD
-0.8 (-7.16%)
Last: 11/20/2025, 8:00:01 PM
10.21 USD
-0.16 (-1.54%)
After Hours: 11/20/2025, 8:00:01 PM
Fundamental Rating

0

Taking everything into account, ETHZ scores 0 out of 10 in our fundamental rating. ETHZ was compared to 533 industry peers in the Biotechnology industry. ETHZ may be in some trouble as it scores bad on both profitability and health. ETHZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ETHZ had negative earnings in the past year.
ETHZ had a negative operating cash flow in the past year.
ETHZ had negative earnings in each of the past 5 years.
In the past 5 years ETHZ always reported negative operating cash flow.
ETHZ Yearly Net Income VS EBIT VS OCF VS FCFETHZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

ETHZ has a worse Return On Assets (-160.73%) than 86.30% of its industry peers.
The Return On Equity of ETHZ (-320.05%) is worse than 72.98% of its industry peers.
Industry RankSector Rank
ROA -160.73%
ROE -320.05%
ROIC N/A
ROA(3y)-229.08%
ROA(5y)-148.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ETHZ Yearly ROA, ROE, ROICETHZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K 10K 15K

1.3 Margins

ETHZ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ETHZ Yearly Profit, Operating, Gross MarginsETHZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

The number of shares outstanding for ETHZ has been increased compared to 1 year ago.
Compared to 5 years ago, ETHZ has more shares outstanding
The debt/assets ratio for ETHZ has been reduced compared to a year ago.
ETHZ Yearly Shares OutstandingETHZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K
ETHZ Yearly Total Debt VS Total AssetsETHZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ETHZ has an Altman-Z score of -0.75. This is a bad value and indicates that ETHZ is not financially healthy and even has some risk of bankruptcy.
ETHZ has a Altman-Z score (-0.75) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.12 indicates that ETHZ is not too dependend on debt financing.
ETHZ has a Debt to Equity ratio of 0.12. This is in the lower half of the industry: ETHZ underperforms 64.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -0.75
ROIC/WACCN/A
WACCN/A
ETHZ Yearly LT Debt VS Equity VS FCFETHZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

ETHZ has a Current Ratio of 0.58. This is a bad value and indicates that ETHZ is not financially healthy enough and could expect problems in meeting its short term obligations.
ETHZ's Current ratio of 0.58 is on the low side compared to the rest of the industry. ETHZ is outperformed by 91.93% of its industry peers.
A Quick Ratio of 0.58 indicates that ETHZ may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.58, ETHZ is doing worse than 91.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.58
ETHZ Yearly Current Assets VS Current LiabilitesETHZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

0

3. Growth

3.1 Past

ETHZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.63%, which is quite impressive.
EPS 1Y (TTM)54.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3124.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ETHZ Yearly Revenue VS EstimatesETHZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2M 4M 6M 8M 10M
ETHZ Yearly EPS VS EstimatesETHZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -1K -2K -3K

0

4. Valuation

4.1 Price/Earnings Ratio

ETHZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ETHZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ETHZ Price Earnings VS Forward Price EarningsETHZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ETHZ Per share dataETHZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ETHZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ETHZILLA CORP

NASDAQ:ETHZ (11/20/2025, 8:00:01 PM)

After market: 10.21 -0.16 (-1.54%)

10.37

-0.8 (-7.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14 2025-11-14
Earnings (Next)03-30 2026-03-30/amc
Inst Owners7.11%
Inst Owner ChangeN/A
Ins Owners4.33%
Ins Owner Change60.27%
Market Cap169.45M
Revenue(TTM)N/A
Net Income(TTM)-17.22M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 31.49
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-127.78
EYN/A
EPS(NY)-3.06
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0
BVpS0.33
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -160.73%
ROE -320.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-229.08%
ROA(5y)-148.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.58
Altman-Z -0.75
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3124.8%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year54.15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.64%
OCF growth 3YN/A
OCF growth 5YN/A

ETHZILLA CORP / ETHZ FAQ

Can you provide the ChartMill fundamental rating for ETHZILLA CORP?

ChartMill assigns a fundamental rating of 0 / 10 to ETHZ.


What is the valuation status of ETHZILLA CORP (ETHZ) stock?

ChartMill assigns a valuation rating of 0 / 10 to ETHZILLA CORP (ETHZ). This can be considered as Overvalued.


What is the profitability of ETHZ stock?

ETHZILLA CORP (ETHZ) has a profitability rating of 0 / 10.


What is the financial health of ETHZILLA CORP (ETHZ) stock?

The financial health rating of ETHZILLA CORP (ETHZ) is 1 / 10.